A case report: Successful management of pulmonary aspergillosis associated with COVID ? 19 ARDS

The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature. © 2022 Ondokuz Mayis Universitesi. All rights reserved. ; DURSUN FIRAT ERGÜL-2021-06-02T11_51_11 ; The patient provided informed consent for the publication of this case. In accordance with the provisions of the Ministry of Health of the Republic of Turkey, the ethics committee of the Ministry of Health was applied and approval was obtained with the number DURSUN FIRAT ERGÜL-2021-06-02T11_51_11. Attached is the e-mail printout showing that it was accepted.